Brief: Tetra Bio-Pharma Provides Update On Commercialization Plan For Its OTC DIN And NHP Product Programs
Jan 20 (Reuters) - Tetra Bio Pharma Inc TBP.V :
* TETRA BIO-PHARMA PROVIDES UPDATE ON ITS COMMERCIALIZATION
PLAN
FOR ITS OTC DIN AND NHP PRODUCT PROGRAMS
* TETRA BIO PHARMA INC - EXPANDING SALES PARTNERSHIP
AGREEMENTS TO
MIDDLE EAST
* TETRA BIO PHARMA - FINALIZING A COMMERCIAL SUPPLY
AGREEMENT &
INITIATING ACTIVITIES TO SECURE PRIVATE REIMBURSEMENT FOR TWO
TERPACAN PRODUCTS
* TETRA BIO PHARMA - IN ADVANCED DISCUSSIONS WITH A MIDDLE
EASTERN
PHARMACEUTICAL CO FOR REGIONAL MANUFACTURING & DISTRIBUTION OF
AWAYE PRODUCT LINE
Source text for Eikon: ID:nGNX52DSJP
Further company coverage: TBP.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tetra Bio Pharma
See all newsBrief: Tetra Bio Receives A Second Clarifax From Health Canada Regarding Reduvo Risk Management Plan
Brief: Tetra Bio-Pharma Announces Results Of Artificial Intelligence Study Of ARDS-003 Combined With Favipiravir
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra Bio-Pharma Provides Update On Patent Applications For Novel Therapeutic Ards-003
Brief: Tetra And Prepaire Jointly Apply To Barda For Funding